This inventor holds 6 USPTO granted patents. Top assignees: The University of Tennessee Research Foundation, Gtx Corporation. Active years: 2002-2009.
Company Filing History:


Years Active: 2002-2009
Title: Sharan Raghow: Innovator in Prostate Cancer Treatment
Introduction
Sharan Raghow is a notable inventor based in Collierville, TN (US). He has made significant contributions to the field of medical research, particularly in the treatment and prevention of prostate cancer. With a total of 6 patents to his name, Raghow's work has the potential to impact the lives of many patients suffering from this condition.
Latest Patents
Raghow's latest patents include innovative methods for addressing androgen-deprivation induced osteoporosis in male subjects suffering from prostate cancer. His first patent outlines a comprehensive approach to treating and preventing osteoporosis and bone fractures, as well as loss of Bone Mineral Density (BMD). This method involves administering a pharmaceutical composition that includes an anti-estrogen agent and its various forms.
Another significant patent focuses on the chemoprevention of prostate cancer. This invention details a method for suppressing or inhibiting latent prostate cancer through the administration of a chemopreventive agent. This agent not only prevents the onset of prostate cancer but also treats existing cases, showcasing Raghow's commitment to advancing cancer treatment.
Career Highlights
Throughout his career, Sharan Raghow has worked with esteemed organizations such as the University of Tennessee Research Foundation and GTx Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field, further enhancing his research and innovations.
Collaborations
Raghow has had the opportunity to work alongside notable colleagues, including Mitchell S. Steiner and Karen A. Veverka. Their combined expertise has contributed to the development of groundbreaking solutions in prostate cancer treatment.
Conclusion
Sharan Raghow's contributions to the field of prostate cancer research are invaluable. His innovative patents and collaborations with leading organizations and experts highlight his dedication to improving patient outcomes. Through his work, Raghow continues to pave the way for advancements in medical treatment.